Posaconazole in prophylaxis and treatment of invasive fungal infections: a pharmacokinetic, pharmacodynamic and clinical evaluation
出版年份 2020 全文链接
标题
Posaconazole in prophylaxis and treatment of invasive fungal infections: a pharmacokinetic, pharmacodynamic and clinical evaluation
作者
关键词
-
出版物
Expert Opinion on Drug Metabolism & Toxicology
Volume -, Issue -, Pages 1-12
出版商
Informa UK Limited
发表日期
2020-06-01
DOI
10.1080/17425255.2020.1764939
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- A non-randomized trial to assess the safety, tolerability, and pharmacokinetics of posaconazole oral suspension in immunocompromised children with neutropenia
- (2019) Antonio C. Arrieta et al. PLoS One
- Clinical Pharmacokinetics, Pharmacodynamics, Safety and Efficacy of Liposomal Amphotericin B
- (2019) Andreas H Groll et al. CLINICAL INFECTIOUS DISEASES
- Preclinical Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antifungal Activity of Liposomal Amphotericin B
- (2019) Jill Adler-Moore et al. CLINICAL INFECTIOUS DISEASES
- Comparative effectiveness of antifungal agents in patients with hematopoietic stem cell transplantation: a systematic review and network meta-analysis
- (2019) Hui-Chen Su et al. Infection and Drug Resistance
- Treatment by posaconazole tablets did not reduced variability of posaconazole trough concentrations compared to posaconazole suspension
- (2019) Elodie Gautier-Veyret et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antifungal drugs: What brings the future?
- (2019) Ruth Van Daele et al. MEDICAL MYCOLOGY
- Low central nervous system posaconazole concentrations during cerebral phaeohyphomycosis
- (2019) François Barde et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Posaconazole Serum Drug Levels Associated with Pseudohyperaldosteronism
- (2019) Minh-Vu H Nguyen et al. CLINICAL INFECTIOUS DISEASES
- Antifungal prophylaxis with posaconazole tablet and oral suspension in patients with haematologic malignancy: Therapeutic drug monitoring, efficacy and risk factors for the suboptimal level
- (2019) Jihyu Oh et al. MYCOSES
- Implications for IV posaconazole dosing in the era of obesity
- (2019) Roeland E Wasmann et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium
- (2019) Oliver A Cornely et al. LANCET INFECTIOUS DISEASES
- High‐dose posaconazole for azole‐resistant aspergillosis and other difficult‐to‐treat mould infections
- (2019) Alexander F. A. D. Schauwvlieghe et al. MYCOSES
- Primary fungal prophylaxis in hematological malignancy: A network meta-analysis of randomized controlled trials
- (2018) Cho-Hao Lee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Co-administration of proton pump inhibitors and/or of steroids may be a risk factor for low trough concentrations of posaconazole delayed-released tablets in adult patients with hematological malignancies
- (2018) Pier Giorgio Cojutti et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline
- (2018) A.J. Ullmann et al. CLINICAL MICROBIOLOGY AND INFECTION
- Primary prophylaxis of invasive fungal infections with posaconazole or itraconazole in patients with acute myeloid leukaemia or high-risk myelodysplastic syndromes undergoing intensive cytotoxic chemotherapy: A real-world comparison
- (2018) Mar Tormo et al. MYCOSES
- Posaconazole–digoxin drug–drug interaction mediated by inhibition of P-glycoprotein
- (2018) Abby C Shumaker et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Pharmacogenomics of triazole antifungal agents: implications for safety, tolerability and efficacy
- (2017) Jarrett R. Amsden et al. Expert Opinion on Drug Metabolism & Toxicology
- Risk factors for suboptimal drug concentration of posaconazole oral suspension in patients with hematologic malignancy
- (2017) E.J. Kim et al. JOURNAL DE MYCOLOGIE MEDICALE
- Risk factors for subtherapeutic levels of posaconazole tablet
- (2017) Laura A Tang et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease
- (2017) Oliver A Cornely et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Safety study and therapeutic drug monitoring of the oral tablet formulation of posaconazole in patients with haematological malignancies
- (2017) C. Boglione-Kerrien et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- A network meta-analysis of primary prophylaxis for invasive fungal infection in haematological patients
- (2017) L. P. Leonart et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- The antifungal pipeline: a reality check
- (2017) John R. Perfect NATURE REVIEWS DRUG DISCOVERY
- Antifungal resistance: current trends and future strategies to combat
- (2017) Nathan Wiederhold Infection and Drug Resistance
- Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
- (2016) Thomas F. Patterson et al. CLINICAL INFECTIOUS DISEASES
- Posaconazole plasma exposure correlated to intestinal mucositis in allogeneic stem cell transplant patients
- (2016) Kim Vanstraelen et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients
- (2016) Frederic Tissot et al. HAEMATOLOGICA
- Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis
- (2016) Francisco M Marty et al. LANCET INFECTIOUS DISEASES
- ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients
- (2016) Frederic Tissot et al. HAEMATOLOGICA
- Role of isavuconazole in the treatment of invasive fungal infections
- (2016) Dustin Wilson et al. Therapeutics and Clinical Risk Management
- Visual Hallucinations Associated with High Posaconazole Concentrations in Serum
- (2015) Leighanne O. Parkes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Effect of a High-Fat Meal on the Pharmacokinetics of 300-Milligram Posaconazole in a Solid Oral Tablet Formulation
- (2015) Wendy M. Kersemaekers et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of Sulfobutylether-β-Cyclodextrin Exposure in a Critically Ill Patient Receiving Intravenous Posaconazole While Undergoing Continuous Venovenous Hemofiltration
- (2015) Amanda A. Morris et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Decreased invasive fungal disease but no impact on overall survival by posaconazole compared to fluconazole prophylaxis: a retrospective cohort study in patients receiving induction therapy for acute myeloid leukaemia/myelodysplastic syndromes
- (2015) Torsten Dahlén et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease
- (2015) Oliver A. Cornely et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Subtherapeutic Posaconazole Exposure and Treatment Outcome in Patients With Invasive Fungal Disease
- (2015) Kim C. M. van der Elst et al. THERAPEUTIC DRUG MONITORING
- Posaconazole Concentrations in Human Tissues after Allogeneic Stem Cell Transplantation
- (2014) Ola Blennow et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Posaconazole Tablet Pharmacokinetics: Lack of Effect of Concomitant Medications Altering Gastric pH and Gastric Motility in Healthy Subjects
- (2014) Walter K. Kraft et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics and Safety Study of Posaconazole Intravenous Solution Administered Peripherally to Healthy Subjects
- (2014) Wendy M. Kersemaekers et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparative Pharmacodynamics of Posaconazole in Neutropenic Murine Models of Invasive Pulmonary Aspergillosis and Mucormycosis
- (2014) Russell E. Lewis et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The role of azoles in the management of azole-resistant aspergillosis: From the bench to the bedside
- (2014) Seyedmojtaba Seyedmousavi et al. DRUG RESISTANCE UPDATES
- Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology
- (2013) H. R. Ashbee et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Therapeutic Drug Monitoring of Posaconazole in Allogeneic Hematopoietic Stem Cell Transplantation Patients Who Develop Gastrointestinal Graft-versus-Host Disease
- (2012) J. Tonini et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multicenter Study of Posaconazole Therapeutic Drug Monitoring: Exposure-Response Relationship and Factors Affecting Concentration
- (2012) Michael J. Dolton et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Single-Dose Phase I Study To Evaluate the Pharmacokinetics of Posaconazole in New Tablet and Capsule Formulations Relative to Oral Suspension
- (2012) Gopal Krishna et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Posaconazole Exposure-Response Relationship: Evaluating the Utility of Therapeutic Drug Monitoring
- (2012) Michael J. Dolton et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Introduction to Drug Pharmacokinetics in the Critically III Patient
- (2012) Brian S. Smith et al. CHEST
- Epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies
- (2012) Mitsutoshi Kurosawa et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- A new solid oral tablet formulation of posaconazole: a randomized clinical trial to investigate rising single- and multiple-dose pharmacokinetics and safety in healthy volunteers
- (2012) G. Krishna et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Hidden Killers: Human Fungal Infections
- (2012) G. D. Brown et al. Science Translational Medicine
- Lack of Evidence for Exposure–Response Relationship in the Use of Posaconazole as Prophylaxis Against Invasive Fungal Infections
- (2011) O A Cornely et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- A post-marketing evaluation of posaconazole plasma concentrations in neutropenic patients with haematological malignancy receiving posaconazole prophylaxis
- (2011) Alexander M. Bryant et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Posaconazole Plasma Concentrations in Critically Ill Patients
- (2011) John Ray et al. THERAPEUTIC DRUG MONITORING
- Steady-State Intrapulmonary Pharmacokinetics and Pharmacodynamics of Posaconazole in Lung Transplant Recipients
- (2010) J. E. Conte et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Posaconazole Serum Concentrations among Cardiothoracic Transplant Recipients: Factors Impacting Trough Levels and Correlation with Clinical Response to Therapy
- (2010) Ryan K. Shields et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical pharmacodynamics and pharmacokinetics of the antifungal extended-spectrum triazole posaconazole: an overview
- (2010) Hans-Peter Lipp BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Exposure–Response of Posaconazole Used for Prophylaxis Against Invasive Fungal Infections: Evaluating the Need to Adjust Doses Based on Drug Concentrations in Plasma
- (2010) S H Jang et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Factors Influencing Pharmacokinetics of Prophylactic Posaconazole in Patients Undergoing Allogeneic Stem Cell Transplantation
- (2009) V. Kohl et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Posaconazole Therapeutic Drug Monitoring: a Reference Laboratory Experience
- (2009) G. R. Thompson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Therapeutic Drug Monitoring of Posaconazole: a Monocentric Study with 54 Adults
- (2009) D. Lebeaux et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Limited penetration of posaconazole into cerebrospinal fluid in an allogeneic stem cell recipient with invasive pulmonary aspergillosis
- (2009) M Reinwald et al. BONE MARROW TRANSPLANTATION
- Pharmacokinetics of a single dose of the antifungal posaconazole as oral suspension in subjects with hepatic impairment
- (2009) Allen Moton et al. CURRENT MEDICAL RESEARCH AND OPINION
- Pharmacokinetics and Absorption of Posaconazole Oral Suspension under Various Gastric Conditions in Healthy Volunteers
- (2008) G. Krishna et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Intrapulmonary Pharmacokinetics and Pharmacodynamics of Posaconazole at Steady State in Healthy Subjects
- (2008) J. E. Conte et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antifungal Therapeutic Drug Monitoring: Established and Emerging Indications
- (2008) D. Andes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Posaconazole concentrations in the central nervous system
- (2008) M. J. G. T. Ruping et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Pharmacokinetics of Oral Posaconazole in Neutropenic Patients Receiving Chemotherapy for Acute Myelogenous Leukemia or Myelodysplastic Syndrome
- (2008) Gopal Krishna et al. PHARMACOTHERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now